What is the equity of Healios KK this year?
Healios KK has equity of 3.86 B JPY this year.
Healios KK Equity 2024
Healios KK Equity
3.86 B JPY
Ticker
4593.T
ISIN
JP3835100003
WKN
A14U80
In 2024, Healios KK's equity was 3.86 B JPY, a -12.03% increase from the 4.38 B JPY equity in the previous year.
Healios KK Aktienanalyse
What does Healios KK do?
Healios KK is a Japanese company founded in 2011. It focuses on the development of neuroscience, particularly the treatment of central nervous system disorders. Healios KK is headquartered in Tokyo and currently employs approximately 100 employees. Business Model: Healios KK aims to develop and market innovative treatments for patients with neurological disorders. The company works closely with research institutes, universities, and other companies to make progress in the development of new drugs and therapies. Healios KK is also involved in clinical research and works to translate its research findings into new products. Divisions: The company focuses on four main areas: - Regenerative Medicine - Stem Cell Therapy - Brain-Computer Interfaces - AI-supported Diagnosis Regenerative Medicine: Healios KK researches new technologies for the treatment of neurological disorders through regenerative medicine, particularly through stem cell therapy. The company collaborates closely with researchers to develop groundbreaking technologies that support the healing of nerve cells and promote brain regeneration. Stem Cell Therapy: Healios KK also focuses on stem cell therapy, which is being investigated in the company's research labs to find new treatment options for patients with spinal injuries, strokes, Parkinson's, and other neurological disorders. Stem cell therapy involves using stem cells to regenerate damaged tissue in the brain or spinal cord. Brain-Computer Interfaces: Healios KK is also working on the development of brain-computer interfaces (BCIs) that aim to establish a direct connection between the brain and a computer. With the help of these interfaces, patients with paralysis or certain neurological disorders can regain control over their movements and activities. Healios KK has developed a smartglove that can be controlled using BCI. AI-supported Diagnosis: Using state-of-the-art artificial intelligence (AI) technologies, Healios KK is developing new and more effective diagnostic methods for neurological disorders. By developing algorithms based on brain scan images, AI-supported diagnoses are expected to be faster and more effective in the future. Products: Healios KK offers a wide range of products and therapies to effectively treat patients with neurological disorders. These include: - Stem Cell Therapy: The company develops and distributes stem cell therapies to treat patients with spinal injuries, strokes, and other neurological disorders. - Smartglove: Healios KK has developed an intelligent glove that is controlled through brain-computer interfaces. The glove is intended for patients who are unable to move their hands due to paralysis. - AI-supported Diagnosis: The company is working on computer-assisted diagnoses of neurological disorders that are more effective and accurate than conventional diagnoses. - Clinical Trials: Healios KK also conducts clinical trials to investigate the effectiveness of new therapies and treatment methods. Summary: Healios KK is a Japanese company focused on developing innovative therapies and treatment methods for neurological disorders. The company works closely with research institutes and other companies to make progress in the development of new drugs and therapies. Healios KK has four main divisions: Regenerative Medicine, Stem Cell Therapy, Brain-Computer Interfaces, and AI-supported Diagnosis. The company offers a variety of products, including stem cell therapy, smartgloves, and AI-supported diagnoses. Healios KK aims to enhance the lives of patients with neurological disorders by using innovative technologies to support their health. Healios KK ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Healios KK's Equity
Healios KK's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Healios KK's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Healios KK's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Healios KK's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Healios KK’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Healios KK stock
What was the equity of Healios KK compared to the previous year?
The equity of Healios KK has increased/decreased by -12.03% decreased compared to the previous year.
What impact does a high equity have on investors of Healios KK?
A high equity is advantageous for investors of Healios KK as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Healios KK?
A low equity can be a risk for investors of Healios KK, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Healios KK affect the company?
An increase in equity of Healios KK can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Healios KK affect the company?
A reduction in equity of Healios KK can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Healios KK?
Some factors that can affect the equity of Healios KK include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Healios KK so important for investors?
The equity of Healios KK is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Healios KK take to change the equity?
To change equity, Healios KK can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Healios KK pay?
Over the past 12 months, Healios KK paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Healios KK is expected to pay a dividend of 0 JPY.
What is the dividend yield of Healios KK?
The current dividend yield of Healios KK is .
When does Healios KK pay dividends?
Healios KK pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Healios KK?
Healios KK paid dividends every year for the past 0 years.
What is the dividend of Healios KK?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is Healios KK located?
Healios KK is assigned to the 'Health' sector.
Wann musste ich die Aktien von Healios KK kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Healios KK from 12/3/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.
When did Healios KK pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of Healios KK in the year 2023?
In the year 2023, Healios KK distributed 0 JPY as dividends.
In which currency does Healios KK pay out the dividend?
The dividends of Healios KK are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Healios KK
Our stock analysis for Healios KK Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healios KK Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
